Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Regencell Bioscience Lim...

    NASDAQ: RGC · Real-Time Price · USD
    62.60
    46.94 (299.74%)
    At close: Jun 16, 2025, 3:59 PM

    Regencell Bioscience Statistics

    Share Statistics

    Regencell Bioscience has 13.01M shares outstanding. The number of shares has increased by 0% in one year.

    Shares Outstanding

    n/a
    		 13.01M

    Shares Change (YoY)

    n/a
    		 0%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 0.24%

    Shares Floating

    n/a
    		 802.14K

    Failed to Deliver (FTD) Shares

    n/a
    		 184

    FTD / Avg. Volume

    n/a
    		 0.07%

    Short Selling Information

    The latest short interest is 20.01K, so 0.15% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 20.01K

    Short % of Shares Out

    n/a
    		 0.15%

    Short % of Float

    n/a
    		 0.82%

    Short Ratio (days to cover)

    n/a
    		 1

    Valuation Ratios

    The PE ratio is -9.71 and the forward PE ratio is null. Regencell Bioscience's PEG ratio is 0.36.

    PE Ratio

    n/a
    		 -9.71

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 5.08

    P/FCF Ratio

    n/a
    		 -10.42

    PEG Ratio

    n/a
    		 0.36
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Regencell Bioscience.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 41.92, with a Debt / Equity ratio of 0.01.

    Current Ratio

    n/a
    		 41.92

    Quick Ratio

    n/a
    		 41.92

    Debt / Equity

    n/a
    		 0.01

    Debt / EBITDA

    n/a
    		 -0.02

    Debt / FCF

    n/a
    		 -0.02

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-358,486.42

    Employee Count

    n/a
    		 12

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by 58203.06% in the last 52 weeks. The beta is 2.62, so Regencell Bioscience's price volatility has been higher than the market average.

    Beta

    n/a
    		 2.62

    52-Week Price Change

    n/a
    		 58203.06%

    50-Day Moving Average

    n/a
    		 9.04

    200-Day Moving Average

    n/a
    		 2.42

    Relative Strength Index (RSI)

    n/a
    		 87.82

    Average Volume (20 Days)

    n/a
    		 255,223

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 -745.59K

    Operating Income

    n/a
    		 -4.74M

    Net Income

    n/a
    		 -4.3M

    EBITDA

    n/a
    		 -3.62M

    EBIT

    n/a
    		 -4.36M

    Earnings Per Share (EPS)

    n/a
    		 -0.33
    Full Income Statement

    Balance Sheet

    The company has 2.96M in cash and 85.74K in debt, giving a net cash position of 2.88M.

    Cash & Cash Equivalents

    n/a
    		 2.96M

    Total Debt

    n/a
    		 85.74K

    Net Cash

    n/a
    		 2.88M

    Retained Earnings

    n/a
    		 -21.62M

    Total Assets

    n/a
    		 8.44M

    Working Capital

    n/a
    		 7.92M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -4M and capital expenditures -5.38K, giving a free cash flow of -4.01M.

    Operating Cash Flow

    n/a
    		 -4M

    Capital Expenditures

    n/a
    		 -5.38K

    Free Cash Flow

    n/a
    		 -4.01M

    FCF Per Share

    n/a
    		 -0.31
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    RGC does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for RGC.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Jun 16, 2025. It was a forward split with a ratio of 38:1.

    Last Split Date

    n/a
    		 Jun 16, 2025

    Split Type

    n/a
    		 forward

    Split Ratio

    n/a
    		 38:1

    Scores

    Altman Z-Score

    n/a
    		 26350.95

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist